相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Autoantibodies in Atrial Fibrillation-State of the Art
Joanna Zygadlo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Therapeutic implications of galectin-3 in patients with atrial fibrillation
Kwang-No Lee et al.
SCIENTIFIC REPORTS (2022)
The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
Grazyna Sygitowicz et al.
BIOMOLECULES (2022)
Circulating Galectin-3 and Aldosterone for Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation
Zhong-bao Ruan et al.
CARDIOVASCULAR THERAPEUTICS (2022)
Markers of Inflammation, Oxidative Stress, and Fibrosis in Patients with Atrial Fibrillation
Priit Pauklin et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)
The predictive value of galectin-3 levels on left atrial low voltage areas assessed by high-density mapping in patients with paroxysmal atrial fibrillation
Gokhan Aksan et al.
JOURNAL OF ARRHYTHMIA (2022)
Galectin-3 is an independent predictor of postoperative atrial fibrillation and survival after elective cardiac surgery
Bernhard Richter et al.
HEART RHYTHM (2022)
Extracellular Vesicles in Atrial Fibrillation-State of the Art
Grzegorz Procyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Circulating plasma galectin-3 predicts new-onset atrial fibrillation in patients after acute myocardial infarction during hospitalization
Qianhui Wang et al.
BMC CARDIOVASCULAR DISORDERS (2022)
Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge
Giuseppe Lippi et al.
INTERNATIONAL JOURNAL OF STROKE (2021)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Galectin-3 levels and the prediction of atrial high-rate episodes in patients with cardiac resynchronization therapy
Gokhan Aksan et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2021)
Galectin-3 in patients with atrial fibrillation and restored sinus rhythm
Antoniya Kisheva et al.
Folia Medica (2021)
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
Eugene S. J. Tan et al.
CLINICAL CHEMISTRY (2021)
Multiple biomarkers measurement to estimate the duration of atrial fibrillation
Chloe Arbault-Biton et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2021)
Plasma Galectin-3 is associated with progression from paroxysmal to persistent atrial fibrillation
Qianhui Wang et al.
BMC CARDIOVASCULAR DISORDERS (2021)
Atrial Fibrillation and Ischemic Stroke: A Clinical Review
Ibrahim Migdady et al.
SEMINARS IN NEUROLOGY (2021)
Analysis of the Correlation of Galectin-3 Concentration with the Measurements of Echocardiographic Parameters Assessing Left Atrial Remodeling and Function in Patients with Persistent Atrial Fibrillation
Pawel Walek et al.
BIOMOLECULES (2021)
Galectin-3 in Cardiovascular Diseases
Valeria Blanda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Circulating Galectin-3 is Associated With Left Atrial Appendage Remodelling and Thrombus Formation in Patients With Atrial Fibrillation
Zhengde Tang et al.
HEART LUNG AND CIRCULATION (2019)
Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients
Kadri Murat Gurses et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2019)
Association of galectin-3 and soluble ST2 with in-hospital and 1-year outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Agata Tyminska et al.
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2019)
The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation
Wouter R. Berger et al.
EUROPACE (2018)
Activation of TGF-β1/α-SMA/Col I Profibrotic Pathway in Fibroblasts by Galectin-3 Contributes to Atrial Fibrosis in Experimental Models and Patients
Hua Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
Nicolas Clementy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation
Gordon A. Begg et al.
EUROPACE (2017)
Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation
Diana Hernandez-Romero et al.
SCIENTIFIC REPORTS (2017)
Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study
Oluwaseun E. Fashanu et al.
AMERICAN HEART JOURNAL (2017)
Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study
Gordon A. Begg et al.
CLINICAL BIOCHEMISTRY (2017)
New onset atrial fibrillation is associated with elevated galectin-3 levels
D. Chen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Galectin-3 in Patients With Paroxysmal and Persistent Atrial Fibrillation and Metabolic Syndrome
V. A. Ionin et al.
KARDIOLOGIYA (2016)
Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation
Nicolas Clementy et al.
SCIENTIFIC REPORTS (2016)
Effects of Persistent Atrial Fibrillation on Serum Galectin-3 Levels
Kadri Murat Gurses et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease
Xiao-Yan Wu et al.
EUROPACE (2015)
The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling
Muhammed U. Yalcin et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2015)
Galectin-3 in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation
Jelena Kornej et al.
PLOS ONE (2015)
Galectin 3 and incident atrial fibrillation in the community
Jennifer E. Ho et al.
AMERICAN HEART JOURNAL (2014)
Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation
Brett Burstein et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)